Improved growth velocity of a patient with Noonan-like syndrome with loose anagen hair (NS/LAH) without growth hormone deficiency by low-dose growth hormone therapy.

Authors:
Kei Takasawa
Kei Takasawa
Tokyo Medical and Dental University
Japan
Shigeru Takishima
Shigeru Takishima
Tokyo Medical and Dental University
Chikako Morioka
Chikako Morioka
Graduate School of Medical and Dental Science
Masato Nishioka
Masato Nishioka
Kyushu University
Japan
Hirofumi Ohashi
Hirofumi Ohashi
Tohoku University School of Medicine
Japan
Yoko Aoki
Yoko Aoki
Tohoku University School of Medicine
New York | United States
Masayuki Shimohira
Masayuki Shimohira
Tokyo Medical and Dental University
Japan
Kenichi Kashimada
Kenichi Kashimada
Tokyo Medical and Dental University
Japan

Am J Med Genet A 2015 Oct 19;167A(10):2425-9. Epub 2015 Jun 19.

Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan.

Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM 607721) is caused by a heterozygous c.4A>G mutation in SHOC2. Most cases exhibit both growth hormone deficiency (GHD) and growth hormone insensitivity (GHI) and thus require a high dose of growth hormone (GH) therapy (e.g., 35-40 µg/kg/day). We report on a genetically diagnosed NS/LAH patient manifesting severe short stature (-3.85 SDs) with low serum level of IGF1, 30 ng/ml. The peak levels of GH stimulation tests were within the normal range, and GHI was not observed in the IGF1 generation test. However, with low-dose GH therapy (25 µg/kg/day) for two years, IGF1 level and height were remarkably improved (IGF1: 117 ng/ml, height SDs: -2.20 SDs). Further, catch-up of motor development and improvement of the proportion of extending limbs to trunk were observed (the Developmental Quotient score increased from 68 to 98 points, and the relative sitting height ratio decreased from 0.62 to 0.57). Our results suggest that endocrinological causes for short stature are variable in NS/LAH and that GH therapy should be considered as a possible treatment for delayed development in NS/LAH.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.37191DOI Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
October 2015
8 Reads

Publication Analysis

Top Keywords

growth hormone
20
hormone therapy
8
syndrome loose
8
anagen hair
8
hair ns/lah
8
hormone deficiency
8
short stature
8
noonan-like syndrome
8
loose anagen
8
ns/lah
5
hormone
5
growth
5
low-dose therapy
4
117 ng/ml
4
ng/ml height
4
igf1 generation
4
generation test
4
test low-dose
4
therapy µg/kg/day
4
igf1 117
4

References

(Supplied by CrossRef)
IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene
Bertelloni et al.
Hormones (Athens) 2013
GH therapy in Noonan syndrome
Dahlgren et al.
Horm Res 2009

Similar Publications